Since cancer driver genes may play the pivotal role in uPAR signaling, we propose to map out this signaling pathway with cancer driver genes for not only clarifying the crosstalk between uPAR signaling and cancer but also providing the intersection drivers in uPAR signaling as druggable hubs for developing small molecule modulators to treat cancer. The gene discussed is PLAUR; the disease is cancer.